(NASDAQ: TLRY) Tilray Brands's forecast annual revenue growth rate of 4.59% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Tilray Brands's revenue in 2025 is $826,656,000.On average, 5 Wall Street analysts forecast TLRY's revenue for 2025 to be $855,213,549,347, with the lowest TLRY revenue forecast at $834,385,122,654, and the highest TLRY revenue forecast at $884,709,918,954. On average, 6 Wall Street analysts forecast TLRY's revenue for 2026 to be $915,156,420,716, with the lowest TLRY revenue forecast at $876,959,900,324, and the highest TLRY revenue forecast at $996,350,447,066.
In 2027, TLRY is forecast to generate $945,124,836,912 in revenue, with the lowest revenue forecast at $891,050,843,288 and the highest revenue forecast at $1,003,476,438,222.